Xilio Therapeutics, Inc. (XLO)
$9.19-0.43%Close
BUYRECOVERY · day 50
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $60M
- Avg volume
- 41.3K
- Beta
- -0.12
- P/E (TTM)
- -6.17
- Short % float
- 18.08%
- Days to cover
- 12.3
- SI change
- +58.8%
- 1W
- -3.16%
- 1M
- +6.24%
- 3M
- +11.39%
- YTD
- -2.23%
- vs SPY 1W
- -1.97%
- vs SPY 1M
- +2.92%
- vs SPY 3M
- +9.00%
- vs SPY YTD
- -13.99%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CORTBUYCorcept Therapeutics IncorporatedBULLQ 22$123.24+0.81%
- USPHBUYU.S. Physical Therapy, Inc.RECOVERYQ 12$77.38-1.06%
- ERNABUYErnexa Therapeutics Inc.RECOVERYQ -2$5.04+3.70%
- VRNOBUYVerano Holdings Corp.RECOVERYQ -10$6.05-2.58%
- IPSCBUYCentury Therapeutics, Inc.RECOVERYQ -13$2.12+2.42%
- BIOBUYBio-Rad Laboratories, Inc.BULLQ 19$381.76+0.46%
- EQSELLEquillium, Inc.CRISISQ 5$2.20-4.76%
- ACHSELLAccendra Health, Inc.CRISISQ 9$1.16-3.33%
- BCYCBUYBicycle Therapeutics plcRECOVERYQ -2$4.33-0.92%
- BJDXSELLBluejay Diagnostics, Inc.CRISISQ -30$0.90-1.10%
- GRIBUYGRI Bio, Inc.RECOVERYQ -30$1.79+8.48%
- PACSSELLPACS Group, Inc.BEARQ 35$44.25+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 21
- VALUE
- 28
- GROWTH
- 47
- GARP
- 8
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-30.5%
REV YoY-
ROE-50.8%
EPS YoY-
ROA-14.2%
GROSS99
OP-49
NET-34
[VALUATION]
P/E TTM-6.17
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B2.47
P/FCF-
EV/EBITDA3.38
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E8.72
ALTMAN Z-
CURR RATIO4.25
ND/EBITDA-
BETA-0.12
